26 reports

  • GLOBAL HPV TESTING MARKET
  • GLOBAL HPV TESTING MARKET

Abbott is one of the major players in the global HPV testing market.

  • HPV Testing
  • World
  • Market Size
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN N.V.

This report presents a detailed analysis of the Pap Smear/ HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; ##-year test volume and sales forecasts by country and market

  • HPV Testing
  • Europe
  • Japan
  • United States
  • World
  • HPV TESTING MARKET IN AMERICAS
  • DEVELOPMENT OF MRNA HPV TEST

Roche Diagnostics opportunity assessment OPPORTUNITY ASSESSMENT Qiagen is one of the global leaders in HPV testing.

  • HPV Testing
  • Abbott Laboratories, Inc.
  • Hologic, Inc.
  • QIAGEN N.V.
  • Roche Group

This report presents a detailed analysis of the Pap Smear/ HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; ##-year test volume and sales forecasts by country and market

  • Diagnostics
  • HPV Testing
  • Demand
  • Forecast
  • Market Size
  • 6.4.2 HPV TEST MARKET
  • 5.4.2 HPV TEST VOLUME

Around ##. ## Million HPV test have completed in China in 2016.

  • Diagnostics
  • HPV Testing
  • China
  • East Asia
  • OriGene Technologies, Inc.
  • SWOT Analysis of Abbott in the HPV & EBV Tests, 2017
  • Device Type

Table ##: North America HPV & EBV Tests Volume Forecast, 2015-2024 (in thousands) Table ##: Europe HPV & EBV Tests Volume Forecast, 2015-2024 (in thousands) HPV Tests ## ## ## ## ## ## ## ##, ## ##, ## ##, ## ##. ##% EBV Tests ## ##

  • HPV Testing
  • Sexually Transmitted Disease
  • Hologic, Inc.
  • QIAGEN N.V.
  • Roche Group

Hoffmann-La Roche Ltd. ##. ## Fujirebio Diagnostics, Inc. ##. ## Hologic, Inc. ##. ## OncoHealth Corporation ##. ## QIAGEN N. V List of Figures FIG. ## Global Cytology and HPV Testing Market Estimates and Forecast, (US$ Mn), 2014–2024 FIG. ## Global HPV Testing Market

  • Diagnostics
  • HPV Testing
  • World
  • Market Size

This report presents a detailed analysis of the Pap Smear/ HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; ##-year test volume and sales forecasts by country and market

  • HPV Testing
  • Europe
  • Japan
  • World
  • Forecast

This report presents a detailed analysis of the Pap Smear/ HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; ##-year test volume and sales forecasts by country and market

  • HPV Testing
  • Europe
  • Japan
  • World
  • Forecast

Europe Pap Smear/ HPV Market, 2019-2023: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts Europe Pap Smear/ HPV Market, 2019-2023: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segmen

  • HPV Testing
  • Europe
  • France
  • Germany
  • Forecast
  • HPV TESTING AND PAP TEST MARKET
  • HPV TESTING AND PAP TEST MARKET

There is one HPV test that has recently been approved (Cobas test) for use as primary cervical cancer screening for women aged ## and older, followed by a Pap test for women with certain results.

  • HPV Testing
  • United States
  • Company
  • Market Segment
  • F. Hoffmann-La Roche Ltd.

This report presents a detailed analysis of the Pap Smear/ HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; ##-year test volume and sales forecasts by country and market

  • Diagnostics
  • HPV Testing
  • Europe
  • France
  • Forecast

2016 Future Horizons and Growth Strategies in the Global Pap Smear/ HPV Testing Market: Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities (DataPack) List of Tables Major Companies Developing or Marketing Pap Smear/ HPV Tests Franc

  • Diagnostics
  • HPV Testing
  • Demand

This report presents a detailed analysis of the Pap Smear/ HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; ##-year test volume and sales forecasts by country and market

  • HPV Testing
  • Europe
  • France
  • Germany
  • Forecast

This report presents a detailed analysis of the Pap Smear/ HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales forecasts by country and market segm

  • HPV Testing
  • Europe
  • France
  • Germany
  • Forecast
  • ATTOSENSE HPV TEST - PRODUCT STATUS
  • ATTOSENSE HPV TEST - PRODUCT DESCRIPTION

HPV TEST SALES.

  • Clinical Trial
  • DNA
  • HPV Testing
  • Sexually Transmitted Disease
  • ValiRx Plc

2016 World Pap Smear/ HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe, Japan (DataPack) List of Tables Major Companies Developing or Marketing Pap Smear/ HPV

  • Diagnostics
  • HPV Testing
  • Japan
  • United States
  • Demand

2016 Europe Pap Smear/ HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--France, Germany, Italy, Spain, UK (DataPack) List of Tables Major Companies Developing or Marketing Pap Smear/

  • HPV Testing
  • France
  • Germany
  • Italy
  • Demand

Distribution Strategies ##.

  • HPV Testing
  • Europe
  • France
  • Germany
  • Demand

Distribution Strategies ##.

  • HPV Testing
  • Europe
  • France
  • Germany
  • Demand
  • HPV test
  • 6.5 PRIMARY HPV TESTING

The Aptima HPV test is one of the leading products in the HPV testing market.

  • Diagnostics
  • Healthcare
  • Hospital
  • HPV Testing
  • Laboratory
  • May 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update for the period ended 31 March 2017
  • Jul 31, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update

Meijer compliant data will support the market positioning of Genera' s PapType®HPV test when the new cervical screening regime is introduced in the Australian market on ## December 2017.

  • Diagnostics
  • HPV Testing
  • Australia
  • Company Financials
  • Genera Biosystems Limited
  • May 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update for the period ended 31 March 2017
  • Jul 31, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update

Meijer compliant data will support the market positioning of Genera' s PapType®HPV test when the new cervical screening regime is introduced in the Australian market on ## December 2017.

  • HPV Testing
  • Molecular Diagnostics
  • Australia
  • Company Financials
  • Genera Biosystems Limited
  • GYNTECT - PRODUCT DESCRIPTION
  • APR 28, 2016: ONCGNOSTICS COOPERATES WITH SAYRE THERAPEUTICS IN INDIA

As a triage test for women tested HPV-positive, GynTect® is also a triage test for PapilloCheck®.

  • Cancer
  • HPV Testing
  • Europe
  • Germany
  • Oncgnostics

MARKET ##.

  • Diagnostics
  • HPV Testing
  • World
  • Company Financials
  • ATTOSENSE HPV TEST - PRODUCT DESCRIPTION
  • ATTOSENSE HPV TEST - PRODUCT STATUS

CLINICALLY VALIDATED BY THE LANDMARK ATHENA TRIAL, THE COBAS HPV TEST PROVIDES SPECIFIC GENOTYPING INFORMATION FOR HPV ## AND HPV ##, THE HIGHEST-RISK TYPES, WHILE SIMULTANEOUSLY REPORTING THE ## OTHER HIGH-RISK HPV TYPES AS A POOLED RESULT, ALL IN

  • Clinical Trial
  • Genome Sequencing
  • HPV Testing
  • Sexually Transmitted Disease
  • Roche Group